GlassScriptPhysician profile
Cheryl Mejia
NPI 1003189515
$19,683.98
in general payments reported to CMS, 2019-2025
42 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $558 · 2021: $2,793 · 2022: $1,299 · 2023: $396 · 2024: $314 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $7,101.56 | 2019-2023 | Relistor |
| Nevro Corp. | $2,463.93 | 2019-2020 | |
| Boston Scientific Corporation | $2,078.81 | 2019-2025 | Intracept |
| Biodelivery Sciences International, INC. | $1,904.07 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $1,260.00 | 2019-2023 | Xtampza |
| Vertos Medical, INC. | $681.07 | 2019-2024 | Mild Device Kit |
| Mallinckrodt Enterprises LLC | $381.49 | 2019 | |
| Pfizer INC. | $314.01 | 2019-2023 | |
| Daiichi Sankyo INC. | $313.51 | 2019 | |
| Horizon Therapeutics Plc | $289.05 | 2019-2022 | |
| Pacira Therapeutics, INC. | $272.11 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $258.31 | 2021 | |
| Mallinckrodt Hospital Products INC. | $219.74 | 2020-2023 | Acthar |
| Abbvie INC. | $203.09 | 2019-2023 | |
| Zyla Life Sciences, INC. | $179.53 | 2019 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Mejia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.